[go: up one dir, main page]

NO20013645L - Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjon av de perifere benzodiazepinreseptorer - Google Patents

Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjon av de perifere benzodiazepinreseptorer

Info

Publication number
NO20013645L
NO20013645L NO20013645A NO20013645A NO20013645L NO 20013645 L NO20013645 L NO 20013645L NO 20013645 A NO20013645 A NO 20013645A NO 20013645 A NO20013645 A NO 20013645A NO 20013645 L NO20013645 L NO 20013645L
Authority
NO
Norway
Prior art keywords
pyridazino
indole
medicines
disease
preparation
Prior art date
Application number
NO20013645A
Other languages
English (en)
Other versions
NO321997B1 (no
NO20013645D0 (no
Inventor
Badia Ferzaz
Jesus Benavides
Frank Marguet
Jacques Froissant
Benoit Marabout
Yannick Evanno
Mireille Sevrin
Philip Janiak
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20013645D0 publication Critical patent/NO20013645D0/no
Publication of NO20013645L publication Critical patent/NO20013645L/no
Publication of NO321997B1 publication Critical patent/NO321997B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20013645A 1999-01-26 2001-07-24 Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av et medikament for forebygging og behandling av sykdommer og lidelser knyttet til dysfunksjonering av perifer-type benzodiazepinreseptorer NO321997B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900806A FR2788696B1 (fr) 1999-01-26 1999-01-26 Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
PCT/FR2000/000135 WO2000044384A1 (fr) 1999-01-26 2000-01-21 UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AUX MALADIES LIEES AU DYSFONCTIONNEMENT DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES

Publications (3)

Publication Number Publication Date
NO20013645D0 NO20013645D0 (no) 2001-07-24
NO20013645L true NO20013645L (no) 2001-09-26
NO321997B1 NO321997B1 (no) 2006-07-31

Family

ID=9541212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013645A NO321997B1 (no) 1999-01-26 2001-07-24 Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av et medikament for forebygging og behandling av sykdommer og lidelser knyttet til dysfunksjonering av perifer-type benzodiazepinreseptorer

Country Status (32)

Country Link
US (1) US6395729B1 (no)
EP (1) EP1148881B1 (no)
JP (1) JP4688295B2 (no)
KR (1) KR100694752B1 (no)
CN (1) CN100577167C (no)
AR (1) AR022413A1 (no)
AT (1) ATE335487T1 (no)
AU (1) AU764445B2 (no)
BG (1) BG65152B1 (no)
BR (1) BR0007718A (no)
CA (1) CA2360754C (no)
CO (1) CO5160242A1 (no)
CY (1) CY1106257T1 (no)
CZ (1) CZ294283B6 (no)
DE (1) DE60029929T2 (no)
DK (1) DK1148881T3 (no)
EE (1) EE04905B1 (no)
ES (1) ES2269097T3 (no)
FR (1) FR2788696B1 (no)
HK (1) HK1040905B (no)
HU (1) HU228670B1 (no)
IL (2) IL144181A0 (no)
NO (1) NO321997B1 (no)
NZ (1) NZ512981A (no)
PL (1) PL193420B1 (no)
PT (1) PT1148881E (no)
RU (1) RU2243764C2 (no)
SK (1) SK285707B6 (no)
TR (1) TR200102134T2 (no)
TW (1) TW541177B (no)
UA (1) UA70349C2 (no)
WO (1) WO2000044384A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201215A2 (en) * 1998-12-02 2002-08-28 Pfizer Prod Inc Methods and compositions for restoring conformational stability of a protein of the p53 family
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2838124B1 (fr) 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
FR2876715B1 (fr) 2004-10-19 2006-12-15 Profiles Du Ct Sa Embout de protection pour ecran de glissiere de securite routiere
GT200600005A (es) * 2005-01-12 2006-08-16 Un derivado de 2-(aminocarbonilo ciclico)-indolina y una composicion farmaceutica que lo contiene
BRPI0611433A2 (pt) * 2005-05-05 2010-09-08 Sanofi Aventis Us Llc formulações estáveis de nanopartìcula
KR20080061354A (ko) * 2005-08-29 2008-07-02 사노피-아벤티스 유.에스. 엘엘씨 7-클로로-Ｎ,Ｎ,5-트리메틸-4-옥소-3-페닐-3,5-디히드로-4Ｈ-피리다지노[4,5-ｂ]인돌-1-아세트아미드의 무정형 고체분산체
ATE531717T1 (de) * 2005-08-29 2011-11-15 Sanofi Aventis Us Llc Neue kristalline form eines pyridazinoä4,5- büindolderivats
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
WO2010021905A1 (en) * 2008-08-18 2010-02-25 Sanofi-Aventis U.S. Llc Process for preparing polymorph of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydr0-4h-pyridazin0[4,5-b]indole-1-acetamide
GB0818738D0 (en) * 2008-10-13 2008-11-19 Ge Healthcare Ltd Imaging neuroflammation
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
EP2181717A1 (en) * 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels
BR112012014661A2 (pt) 2009-12-18 2020-12-29 L'oreal Processo de tratamento cosmético da pele e conjunto cosmético
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121137A1 (de) * 1981-05-27 1982-12-16 Hoechst Ag, 6000 Frankfurt Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung"
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6031120A (en) * 1997-07-29 2000-02-29 E. I. Du Pont De Nemours And Company Selective synthesis of organodiphosphite compounds
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
DK1148881T3 (da) 2006-12-11
JP4688295B2 (ja) 2011-05-25
BG65152B1 (bg) 2007-04-30
EP1148881A1 (fr) 2001-10-31
DE60029929D1 (de) 2006-09-21
HK1040905B (zh) 2007-02-23
HUP0201280A3 (en) 2004-12-28
EE04905B1 (et) 2007-10-15
DE60029929T2 (de) 2007-08-30
TR200102134T2 (tr) 2003-03-21
US6395729B1 (en) 2002-05-28
HU228670B1 (en) 2013-05-28
IL144181A0 (en) 2002-05-23
RU2243764C2 (ru) 2005-01-10
FR2788696B1 (fr) 2004-03-05
ATE335487T1 (de) 2006-09-15
CA2360754A1 (en) 2000-08-03
NZ512981A (en) 2002-10-25
CN100577167C (zh) 2010-01-06
TW541177B (en) 2003-07-11
NO321997B1 (no) 2006-07-31
KR20010089624A (ko) 2001-10-06
PT1148881E (pt) 2006-12-29
KR100694752B1 (ko) 2007-03-14
SK10502001A3 (sk) 2002-01-07
AR022413A1 (es) 2002-09-04
CA2360754C (en) 2008-07-08
NO20013645D0 (no) 2001-07-24
HUP0201280A2 (en) 2002-08-28
CN1344161A (zh) 2002-04-10
SK285707B6 (sk) 2007-06-07
BR0007718A (pt) 2001-11-13
JP2002535370A (ja) 2002-10-22
WO2000044384A1 (fr) 2000-08-03
CO5160242A1 (es) 2002-05-30
CZ20012681A3 (cs) 2001-10-17
AU3057900A (en) 2000-08-18
AU764445B2 (en) 2003-08-21
HK1040905A1 (en) 2002-06-28
EE200100388A (et) 2002-12-16
ES2269097T3 (es) 2007-04-01
EP1148881B1 (fr) 2006-08-09
CZ294283B6 (cs) 2004-11-10
PL349364A1 (en) 2002-07-15
UA70349C2 (en) 2004-10-15
PL193420B1 (pl) 2007-02-28
BG105728A (en) 2002-02-28
CY1106257T1 (el) 2011-06-08
FR2788696A1 (fr) 2000-07-28
IL144181A (en) 2007-06-17

Similar Documents

Publication Publication Date Title
NO20013645L (no) Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjon av de perifere benzodiazepinreseptorer
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0102300A3 (en) Use of diazepin derivatives for preparing medicines for treating diseases influenced by somatostatine receptor, and new compounds
EE04613B1 (et) Sahhariidijääkidega asendatud 1,4-bensotiasepiin-1,1-dioksiidi derivaadid, meetod nende valmistamiseks, ühendite kasutamine ning neid sisaldav ravim
FR2786770B1 (fr) Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
EP0982030A3 (en) 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
WO2000012623A3 (en) Use of 5-th receptor antagonists for the treatment of parkinson's disease
EE200100377A (et) Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
HUP0002963A3 (en) Use of pyrazolo-[4,3-d] pyrimidinon derivatives for the production of pharmaceutical compositions for treating diseases of the eye field
NZ515882A (en) Treatment of serotonin related disorders with 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives
PT1105390E (pt) Derivados de imidazo¬1,2-a|piridina para o tratamento de doencas gastrointestinais
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
PT1152756E (pt) Derivados de anticonvulsivo uteis no tratamento do autismo
HUP0300569A3 (en) Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders and pharmaceutical compositions containing the compounds
EE200000537A (et) Pürasolo[4,3-d]pürimidiin-7-oon-3-püridüülsulfonüülühendite ja nende vaheühendite valmistamise protsess
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
AU6076000A (en) Cyclic amine derivatives for the treatment of neurological diseases
NO20022456D0 (no) Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon
NO20014383L (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
AU2001278549A1 (en) Use of pyridazino(4,5-)indole-1-acetamide derivatives for preparing medicines for treating pathologies related to the dysfunction of peripheral benzodiazepin receptors
NO20016271D0 (no) Fremgangsmåte for fremstilling av substituerte [1,4]diazepino[6,7,1-hi]indol-4-oner
NO20014729L (no) Derivater av pyrimido[6,1-a] isokinolin-4-on
NO20020670D0 (no) Fremgangsmåte for fremstilling av kinolin-5,8-dioner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees